Table 2. Characteristics of patients with CHF.
E+P | |||||||
---|---|---|---|---|---|---|---|
Number of patients | 7 | ||||||
Age (years) | 71 | 67 | 61 | 46 | 56 | 46 | 70 |
PS (ECOG) | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Prior adjuvant E (360 mg m−2) | No | Yes | No | Yes | Yes | Yes | No |
Left breast radiotherapy | No | Yes | Yes | Yes | Yes | Yes | Yes |
Baseline LVEF (%) | 50 | 58 | 60 | 50 | 55 | 55 | 55 |
CHF class NYHA | IV | III | III | IV | IV | IV | III |
E cumulative dose (mg m−2) | 90 | 630 | 720 | 1080 | 1080 | 1080 | 360 |
Death due heart failure | Yes | No | No | No | No | No | No |
CHF=congestive heart failure; LVEF=left ventricular ejection fraction; NYHA=New York Heart Association. PS=performance status; ECOG=European Collaborative Oncology Group